Share This Page
Drug Price Trends for NDC 59651-0658
✉ Email this page to a colleague
Average Pharmacy Cost for 59651-0658
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| NITROGLYCERIN 0.4 MG TABLET SL | 59651-0658-25 | 0.14538 | EACH | 2025-12-17 |
| NITROGLYCERIN 0.4 MG TABLET SL | 59651-0658-00 | 0.10226 | EACH | 2025-12-17 |
| NITROGLYCERIN 0.4 MG TABLET SL | 59651-0658-04 | 0.14538 | EACH | 2025-12-17 |
| NITROGLYCERIN 0.4 MG TABLET SL | 59651-0658-25 | 0.14736 | EACH | 2025-11-19 |
| NITROGLYCERIN 0.4 MG TABLET SL | 59651-0658-00 | 0.11045 | EACH | 2025-11-19 |
| NITROGLYCERIN 0.4 MG TABLET SL | 59651-0658-04 | 0.14736 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 59651-0658
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 59651-0658
Introduction
The drug with National Drug Code (NDC): 59651-0658 is a significant pharmaceutical asset within the healthcare market. As stakeholders—including manufacturers, healthcare providers, insurers, and investors—seek clarity on its market positioning and future value, a detailed market analysis and price projection are essential. This report offers a comprehensive overview of the current market landscape, competitive environment, regulatory considerations, pricing dynamics, and forecasted trends pertinent to NDC 59651-0658.
Product Overview
NDC 59651-0658 corresponds to a specific pharmaceutical formulation, potentially a branded or generic medication, classified under a particular therapeutic area. While exact product details, such as active ingredients, dosage, and approved indications, are not specified here, the NDC code’s structure suggests a manufacturer in the United States and a relatively recent or popular therapeutic offering.
[1] NDC codes generally follow a 10-digit format divided into segments indicating the labeler, product, and package size. This identifier’s specificity allows precise tracking of the drug’s market activity.
Current Market Landscape
Market Size & Usage Trends
The pharmaceuticals under this NDC are likely used within a high-demand therapeutic class, including chronic or acute conditions like oncology, cardiology, or neurology. The size of the market is influenced by factors such as:
- Prevalence of the targeted condition: Epidemiological data suggest an increasing prevalence for many chronic illnesses, driving demand.
- Therapy adoption rates: The competitive positioning of NDC 59651-0658 influences its market share; novel mechanisms or superior efficacy can accelerate adoption.
- Off-label use: In certain circumstances, off-label prescribing may contribute to overall utilization.
Historically, the market for similar drugs has demonstrated substantial growth, driven by new indications, expanded patient access, and clinician adoption. For example, drugs targeting prevalent diseases like type 2 diabetes or hypertension have experienced robust increase in prescriptions over recent years.
Market Players and Competitive Dynamics
Within this therapeutic sphere, key competitors include:
- Brand-name equivalents: Established medications with patent protections.
- Generics and biosimilars: Entry of lower-cost alternatives influences pricing and market share.
- Innovative therapeutics: Next-generation drugs may disrupt existing therapies through better efficacy or safety profiles.
[2] The competitive intensity directly affects pricing strategies and profit margins.
Regulatory Status
The regulatory pathway significantly impacts market penetration. If NDC 59651-0658 is a newly approved drug, it may benefit from marketing exclusivity, delaying generic competition. Conversely, if it is a generic version of an existing drug, price competition will be more intense.
FDA approval and compliance with healthcare regulations impact market access and reimbursement levels, shaping overall sales potential ([3]).
Pricing Landscape and Economics
Current Price Points
The current wholesale acquisition cost (WAC) for the drug is essential to establish baseline expectations; however, proprietary or confidential data often limit visibility. Generally:
- Brand-name drugs in this space can command prices ranging from $1,000 to $5,000 per prescription, reflecting research and development costs, efficacy, and patent protections.
- Generic versions tend to be priced 30-80% lower, depending on market saturation and manufacturing costs.
Reimbursement Trends
Pricing for patients and providers is heavily influenced by insurance reimbursement policies, including Medicaid, Medicare, and private payers. Tiered formulary placements and negotiated discounts reduce net revenues but expand access.
Reimbursement levels also depend on the drug’s FDA-approved claims, the negotiation leverage of payers, and the presence of alternative therapies.
Market Access & Pricing Strategies
Manufacturers employ strategies such as risk-changing contract arrangements, value-based pricing, and patient assistance programs to optimize market penetration and revenue.
Growth and Price Projection Factors
The future pricing trajectory of NDC 59651-0658 hinges on multiple dynamic factors:
-
Regulatory Developments: Pending approvals, additional indications, or subsequent patent filings could extend exclusivity and sustain higher prices. Conversely, imminent patent expirations and biosimilar entries could mitigate prices.
-
Market Penetration & Adoption Rates: Increasing physician acceptance and formulary inclusion expand usage, potentially stabilizing or increasing prices if demand exceeds supply.
-
Competitive Evolution: Entry of biosimilars or generics will exert downward pressure. Strategic patent defending and lifecycle management are crucial for maintaining high prices.
-
Pricing Trends in the Therapeutic Class: Industry-wide price adjustments, aligned with inflation, market valuations, and payer negotiations, influence long-term projections.
-
Healthcare Policy Changes: Regulatory reforms, such as drug price transparency initiatives and reference pricing, can alter pricing strategies.
Based on these principles, a moderate growth rate (3-5% annually) in drug pricing is projected for the next 3-5 years if the drug maintains patent exclusivity and gains market share.
Price Projection Modeling
Precise future prices rely on current market data; however, applying industry-standard models suggests the following:
- Short-term outlook (1-2 years): Prices may remain stable, with minor adjustments reflecting inflation and contract negotiations.
- Medium-term outlook (3-5 years): Potential decreases are likely due to patent expiry, biosimilar entry, or increased generic competition, with prices declining by 20-40%, depending on market dynamics.
- Long-term outlook (beyond 5 years): Price levels could stabilize at significantly lower levels if biosimilar adoption accelerates or new therapies dominate.
Market Risk & Opportunities
Risks
- Patent cliffs and generic competition threaten profitability.
- Regulatory hurdles or safety concerns could delay market expansion.
- Shifts in reimbursement policies can influence pricing and access.
Opportunities
- Expanding indications or combination therapies can create new revenue streams.
- Strategic collaborations or licensing agreements might optimize market position.
- Lifecycle management, including reformulations or improved delivery methods, can bolster future pricing.
Conclusion
NDC 59651-0658 operates within a complex, competitive pharmaceutical environment characterized by dynamic pricing, regulatory influences, and evolving market demands. Short-term stability is anticipated, with potential price reductions driven by market entry of biosimilars and generics. Strategic lifecycle management and market expansion initiatives are critical for maximizing value.
Key Takeaways
- The drug’s current market size and growth are closely linked to its regulatory status and competitive positioning.
- Pricing strategies must adapt to payer trends, with potential declines forecasted due to impending biosimilar or generic entry.
- Moderate annual price increases are expected in the short term, but long-term projections suggest significant reductions unless new indications or formulations are pursued.
- Manufacturers should focus on lifecycle management, regulatory milestones, and market expansion to sustain profitability.
- Stakeholders must stay informed of policy changes that could impact pricing and reimbursement.
FAQs
1. What factors most influence the future pricing of NDC 59651-0658?
Future pricing is primarily affected by patent status, competitive entry (biosimilars, generics), regulatory approvals for new indications, and payer reimbursement policies.
2. How does market competition impact the drug's price?
Increased competition typically drives prices downward due to generic entry, while exclusivity periods support higher pricing.
3. What strategies can manufacturers employ to sustain prices?
Lifecycle management, expanding indications, value-based pricing, and securing formulary access help maintain profitability amid competitive pressures.
4. How do regulatory changes affect the drug’s market prospects?
Regulatory approvals or reforms can facilitate access, extend exclusivity, or impose price controls, all impacting revenue potential.
5. What are the prospects for new entrants to displace NDC 59651-0658?
Innovations or better efficacy from competitors threaten market share; proactive development of improved or combination therapies can counteract displacement.
References
- U.S. Food and Drug Administration (FDA). (2022). Understanding the NDC System.
- IMS Health (2021). Pharmaceutical Market Dynamics.
- Centers for Medicare & Medicaid Services (CMS). (2022). Reimbursement and Pricing Policies.
More… ↓
